Key facts
- Notable investors include HiCenter, ICI Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for BioStream
- ·The full record, as it builds
Funding rounds
No funding rounds for BioStream are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BioStream
Developer of urine biomarker diagnostic equipment designed for non-invasive health monitoring and early detection of neurological and other health conditions. The company's platform provides at-home urine testing with multiplex and sensitive lateral flow immunoassay technology, supports automatic data capture, provides rapid analysis of multiple biomarkers from a single sample, integrates with digital health records, and facilitates continuous health monitoring for individuals and healthcare providers, enabling the healthcare market to access timely, actionable health insights without the need for laboratory visits.
- Sector
- Healthcare
- HQ
- Fort Collins, CO, United States
- Founded
- 2025
- Employees
- 2
- Website
- biostream.health/
- Ownership
- Privately Held (backing)
BioStream doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioStream shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioStream in its N-PORT filings yet. We sweep new filings monthly.